CN101864046A - Glucosamine modified poly (ethylene glycol) diacrylate (PEGDA) hydrogel, preparation method and application thereof - Google Patents
Glucosamine modified poly (ethylene glycol) diacrylate (PEGDA) hydrogel, preparation method and application thereof Download PDFInfo
- Publication number
- CN101864046A CN101864046A CN 201010199878 CN201010199878A CN101864046A CN 101864046 A CN101864046 A CN 101864046A CN 201010199878 CN201010199878 CN 201010199878 CN 201010199878 A CN201010199878 A CN 201010199878A CN 101864046 A CN101864046 A CN 101864046A
- Authority
- CN
- China
- Prior art keywords
- glucosamine
- preparation
- hydrogel
- pegda
- diacrylate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Materials For Medical Uses (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a glucosamine modified poly (ethylene glycol) diacrylate (PEGDA) hydrogel, a preparation method and application thereof. The glucosamine modified poly (ethylene glycol) diacrylate hydrogel contains 10-30 percent of poly (ethylene glycol) diacrylate, 1.0-10mM of acryloyl or propenyl glucosamine and 0.03-0.1 percent of initiating agent I2959. The preparation method comprises the steps of: preparing the PEGDA by using polyethyleneglycol as a basic material; preparing the acryloyl or propenyl glucosamine by using glucosamine hydrochloride as a raw material; and preparing a water solution or PBS (Poly (Butadiene-Styrene) solution by using the acryloyl or propenyl glucosamine and the initiating agent I2959 in a certain proportion, and can be cured into the hydrogel after being irradiated by ultraviolet with 365nm wavelength. The hydrogel can be used for tissue repair of clinical medicine, has simple preparation process, can realize in situ injection forming, meet the requirement on minimally invasive procedure, and has better application prospect and scientific significance.
Description
Technical field
The present invention relates to a kind of modified biological material and technology of preparing thereof, particularly a kind ofly have good biocompatibility and bioactive glucosamine modified poly (ethylene glycol) diacrylate (PEGDA) hydrogel and preparation method thereof and application concurrently.
Background technology
Glucosamine is to form cartilage cell epimatrix glycosaminoglycan, hyaluronic structural unit.Glucosamine hydrochloride or vitriol are as a kind of medicine of clinical treatment osteoarthritis, and the pain of energy reduction of patient can reduce joint cavity and narrow down.Though its pharmacological action is not clear, experiment in vitro shows that finite concentration (adding 2mM in the substratum) glucosamine can promote the chondrocyte's secretory protein glycan and the II collagen of dimensional culture, can raise the expression of TGFb-1 among the chondrocyte mRNA; Can promote the embryonic stem cell differentiating cartilage-forming cell of dimensional culture.The gel of covalent attachment glucosamine can promote wound healing, can mediate host cell and grow into, and improves the biocompatibility of material greatly.
Gel be owing to can allow the chondrocyte keep its phenotype, and nutritive substance and metabolic waste can spread and become cartilage tissue engineered ideal support.The PEG drugs approved by FDA is used for clinical bio-medical material, though PEG double methacrylate gel is a biocompatible materials, lacks biological activity and cell recognition signal, is unfavorable for the cell-specific gene activation.It is the effective means of preparation biologically active functional gel that the biological activity small molecules is attached in the support.
Summary of the invention
The objective of the invention is to biological activity small molecules glucosamine is attached in the PEGDA gel, a kind of glucosamine modified poly (ethylene glycol) diacrylate (PEGDA) hydrogel that has good biocompatibility concurrently and can promote chondrocyte's secretory protein glycan is provided.
Another object of the present invention is to provide the preparation method of above-mentioned glucosamine modified poly (ethylene glycol) double methacrylate (PEGDA) hydrogel.
The present invention also has a purpose to be to provide glucosamine modified PE GDA preparing gel Application of Biomaterial.
Purpose of the present invention is achieved through the following technical solutions:
A kind of glucosamine modified poly (ethylene glycol) diacrylate (PEGDA) hydrogel has following structure:
Wherein R is
Or
N is 45～230.
A kind of preparation method of glucosamine modified poly (ethylene glycol) diacrylate (PEGDA) hydrogel comprises the steps:
(1) glucosamine acryloyl derivative or glucosamine propenyl derivatives and polyoxyethylene glycol double methacrylate are dissolved in the aqueous solution or the PBS (phosphate buffer solution) that weight fraction is 0.03%～0.08% I2959 (2-hydroxyl-4-(2-hydroxy ethoxy)-2-methyl phenyl ketone), the ultimate density of glucosamine acryloyl or propenyl derivatives is 1.0mM～10.0mM in the mixed solution that obtains, and the ultimate density of polyoxyethylene glycol double methacrylate is 10%～30wt%;
(2) mixed solution is shone 4～10min under the 365nm wavelength, the irradiates light light intensity is 5～10mW/cm
2, promptly get glucosamine modified poly (ethylene glycol) diacrylate (PEGDA) hydrogel of the present invention.
Every material that contains acryloyl group all is to realize of the present inventionly in the described glucosamine acryloyl derivative, comprises N-acryl glucosamine.
The preparation method of described N-acryl glucosamine comprises the steps:
(1) mixed solvent of glucosamine hydrochloride is water-soluble or water and acetone, regulating the pH value is 8～10, drips acrylate chloride under the ice-water bath condition, slowly be warming up to room temperature behind the reaction 2h, continue reaction 24h, add 99% (percent by volume) ethanol termination reaction, remove by filter precipitation
(2) filtrate concentrating separated out white needle-like crystals, recrystallization purification crystal; The mol ratio of glucosamine hydrochloride and acrylate chloride is 1: 1.5～1: 1.
Every material that contains carbon-carbon double bond can be realized purpose of the present invention in the described glucosamine propenyl derivatives, comprises the glucosamine allyl ether.
The preparation method of described glucosamine allyl ether is as follows:
The pH value of aqueous solution of regulating glucosamine hydrochloride is 8～10, adds sodium borohydride, under 40 ℃, dropwise adds allyl bromide 98, slowly is warming up to 60 ℃ of reaction 3h then, and solution washs to chloroform layer colourless through chloroform; With the lyophilize of aqueous solution part, ethyl alcohol recrystallization; The mol ratio of glucosamine hydrochloride and allyl bromide 98 is 1: 1.5～1: 3.
Described polyoxyethylene glycol double methacrylate can adopt the commodity on the market, also can adopt following method synthetic, and step is as follows:
Take by weighing the polyoxyethylene glycol of 50 grams, be dissolved in the 700ml toluene, reflux, after removing moisture in the raw material with water trap, be cooled to room temperature, under high purity nitrogen protection, add the anhydrous triethylamine that is four times in polyoxyethylene glycol terminal hydroxy group amount of substance, dropwise add the acrylate chloride that is four times in polyoxyethylene glycol terminal hydroxy group amount of substance, stir down at 35 ℃ and spend the night; Remove by filter the precipitation that reaction generates, add ether in the filtrate and place 4 ℃ of refrigerators, separate out white precipitate, filter, will precipitate and be dissolved in the 100ml toluene adding ether again, place 4 ℃ of refrigerators, separate out white precipitate, repeat to filter and dissolve twice again, the gained white precipitate is in the dry 24h of 35 ℃ of vacuum drying ovens.
The number-average molecular weight of described polyoxyethylene glycol is 2000～10000.
The application of a kind of glucosamine modified poly (ethylene glycol) diacrylate (PEGDA) hydrogel in cartilage tissue engineered.
Though PEG double methacrylate gel is a biocompatible materials, lack biological activity and cell recognition signal, be unfavorable for the cell-specific gene activation.Saccharide compound plays an important role in vital movement processes such as signal identification and signal conduction.Glucosamine is a kind of amino monose, is one of structural unit of forming the cartilage cell epimatrix glycosaminoglycan, also is the depot drug product of clinical treatment osteoarthritis.The cell in vitro experiment shows, adds chondrocyte's secretory protein glycan and II collagen that glucosamine can promote dimensional culture, can raise the expression of TGFb-1 among the chondrocyte mRNA; Can promote the embryonic stem cell differentiating cartilage-forming cell of dimensional culture.The present invention connects two keys on glucosamine, utilize ultraviolet light cross-linking technology and PEGDA crosslinked, prepares the hydrogel support of a kind of biological activity small molecules glucosamine modification, is used for cartilaginous tissue and makes up.
Principle of the present invention: glucosamine is a kind of pyranoid ring monose, the hydroxy amino that can react is arranged on the ring, can be by amidation, esterification or etherification reaction are introduced two keys, with PEGDA under action of ultraviolet light, initiator I2959 produces free radical with two key effects, and two key glucosamines of band and PEGDA are cross-linked to form hydrogel.
The present invention compared with prior art has following advantage:
(1) hydrogel material of the present invention contains biological activity small molecules glucosamine, makes it have specific biological function and excellent biological compatibility.
(2) the present invention can regulate mechanical property, the swelling ratio of gel by changing molecular weight and the consumption of PEGDA.
(3) material package bone marrow interstital stem cell of the present invention can promote it to be divided into cartilage, improves the glycosaminoglycan secretory volume.
(4) technology of the present invention's employing is simple, helps large-scale production.
Description of drawings
Fig. 1 be before and after the material gelization proton nuclear magnetic resonance spectroscopy figure (
1H-NMR).
Fig. 2 is the total reflection Fourier infrared spectrogram (ATR-FTIR) of gelatinous material.
Fig. 3 is the chemical structural formula of gelatinous material.
Fig. 4 is the fluorescent microscope photo that the gel of embodiment 2 preparations encapsulates the bone marrow interstital stem cell of green fluorescent protein mark.
Fig. 5 is the bone marrow interstital stem cell (GFP-BMSCs) of the gel encapsulation green fluorescent protein mark of embodiment 3 preparations, cultivates 28 days glycosaminoglycan result.
Fig. 6 is the structural formula of embodiment 4 gels
Embodiment
For better understanding the present invention, below in conjunction with embodiment the present invention is described further, but the scope of protection of present invention is not limited to the scope that embodiment represents.
Embodiment 1
Preparation glucosamine modified PE GDA hydrogel comprises the steps:
(1) the polyoxyethylene glycol double methacrylate is synthetic
Take by weighing the polyoxyethylene glycol (number-average molecular weight 4000) of 50 grams; be dissolved in the 700ml toluene; reflux; after removing moisture content in the raw material with water trap; be cooled to room temperature, under high purity nitrogen protection, add 0.1 mole of anhydrous triethylamine; dropwise add 0.1 mol propylene acyl chlorides, stirred 24 hours down at 35 ℃.Remove by filter the precipitation that reaction generates, add 300 milliliters of ether in the filtrate and place 4 ℃ of refrigerators, separate out white precipitate, filter, to precipitate and be dissolved in again in the 100ml benzene, add 200 milliliters of ether, separate out white precipitate in 4 ℃ of refrigerators, repeat to filter and dissolve twice, the gained white precipitate was in dry 24 hours of 35 ℃ of vacuum drying ovens again.
(2) N-acryl glucosamine (AGA) is synthetic: 8.6 gram glucosamine hydrochlorides are dissolved in 40ml water; the regulator solution pH value is 8～10; under the ice-water bath condition, drip 3.5 milliliters of acrylate chlorides; react and slowly be warming up to room temperature after 2 hours; continue reaction 24 hours, add 200 milliliter of 99% (percent by volume) ethanol termination reaction, remove by filter the salt that reaction produces; filtrate concentrating separated out white needle-like crystals, recrystallization purification crystal.
(3) preparation of N-acryl glucosamine modified PE GDA gel
1g polyoxyethylene glycol double methacrylate and 1.2mgN-acrylamido glucose are dissolved in the I2959PBS solution of 5ml 0.03% weight; The ultimate density of N-acrylamido glucose is 1.0mM in the mixed solution that obtains, and the ultimate density of polyoxyethylene glycol double methacrylate is 20wt%; With 96 orifice plates is mould, draw the above-mentioned solution of 40ul and place orifice plate, and at 365nm, 5mW/cm
2Under the UV-light according to 10min gelatinous material of the present invention.Fig. 3 is embodiment 1 a gel chemical structural formula, and n is 45.
As shown in Figure 1,
1H-NMR analyzes confirmation, before the gelation of material prepolymer solution, end thiazolinyl CH occurs at chemical shift δ 5.5～6.5ppm place
2The absorption peak of=CH-, after the gelation, this place's absorption peak disappears, and illustrates that radical addition polymerization has taken place the end thiazolinyl of glucosamine and PEGDA.1646cm on the ATR-FTIR spectrogram behind the gel refrigeration drying shown in Figure 2
-1And 1548cm
-1The charateristic avsorption band of acid amides I band and II band has appearred in the place, confirms that further glucosamine and PEGDA under UV-irradiation radical addition polymerization have taken place, and have formed cross linked gel.
Embodiment 2
(1) the polyoxyethylene glycol double methacrylate is synthetic
Take by weighing the polyoxyethylene glycol (number-average molecular weight 10000) of 50 grams; be dissolved in the 700ml toluene; reflux; after removing moisture content in the raw material with water trap; be cooled to room temperature, under high purity nitrogen protection, add 0.04 mole of anhydrous triethylamine; dropwise add 0.04 mol propylene acyl chlorides, stirred 24 hours down at 35 ℃.Remove by filter the triethylamine salt that reaction generates, add 300 milliliters of ether in the filtrate and place 4 ℃ of refrigerators, separate out white precipitate, filter, to precipitate and be dissolved in again in the 100ml benzene, add 200 milliliters of ether, separate out white precipitate in 4 ℃ of refrigerators, repeat to filter and dissolve twice, the gained white precipitate is in the dry 24h of 35 ℃ of vacuum drying ovens again.
(2) N-acryl glucosamine is synthetic: the 8.6g glucosamine hydrochloride is dissolved in 30ml water and the 10ml acetone mixed solvent; the regulator solution pH value is 8～10; under the ice-water bath condition, drip acrylate chloride 3.5ml; slowly be warming up to room temperature behind the reaction 2h; continue reaction 24h, add 200 milliliter of 99% (percent by volume) ethanol termination reaction, remove by filter the salt that reaction produces; filtrate concentrates the adularescent needle-like crystal and separates out recrystallization purification crystal.
(3) preparation of N-acryl glucosamine modified PE GDA gel
Preparation glucosamine modified PE GDA hydrogel comprises the steps: that (1) is dissolved in 1.5g polyoxyethylene glycol double methacrylate and 11.6mg N-acrylamido glucose the phosphate buffer solution of pH value 7.4 of the I2959 of 5ml 0.06%; The ultimate density of N-acrylamido glucose is 10.0mM in the mixed solution that obtains, and the ultimate density of polyoxyethylene glycol double methacrylate is that 30wt% (2) is a mould with 96 orifice plates, draw 40ul step (1) solution and place orifice plate, and at 365nm, 7mW/cm
2Under the UV-light according to 7min gelatinous material of the present invention.
The bone marrow interstital stem cell step of glucosamine modified PE GDA gelinite outer package green fluorescent protein mark: (1) is with disinfectant 1.5g polyoxyethylene glycol double methacrylate and 11.6mg N-acrylamido glucose are dissolved in the I2959PBS solution of 5ml 0.06% weight; (2) draw the above-mentioned solution of 2ml, mix with the rat mesenchymal stem cells suspension of equivalent green fluorescent protein mark; (3) be mould with 96 orifice plates, draw step 2 solution 40ul in orifice plate, at 365nm, 7mW/cm
2According to 7min, place 2 orifice plates to cultivate the gel cell conjugate under the UV-light.
Fig. 4 is the fluorescent microscope photo that the gel of embodiment 2 preparations encapsulates the bone marrow interstital stem cell vitro culture 7d of green fluorescent protein mark.The strong green fluorescence of cell expressing among the figure, the testimonial material biocompatibility is good.
Embodiment 3
(1) the polyoxyethylene glycol double methacrylate is synthetic
Take by weighing the polyoxyethylene glycol (number-average molecular weight 10000) of 50 grams; be dissolved in the 700ml toluene; reflux; after removing moisture content in the raw material with water trap; be cooled to room temperature, under high purity nitrogen protection, add 0.04 mole of anhydrous triethylamine; dropwise add 0.04 mol propylene acyl chlorides, stirred 24 hours down at 35 ℃.Remove by filter the triethylamine salt that reaction generates, add 300 milliliters of ether in the filtrate and place 4 ℃ of refrigerators, separate out white precipitate, filter, to precipitate and be dissolved in again in the 100ml benzene, add 200 milliliters of ether, separate out white precipitate in 4 ℃ of refrigerators, repeat to filter and dissolve twice, the gained white precipitate is in the dry 24h of 35 ℃ of vacuum drying ovens again.
(2) N-acryl glucosamine is synthetic: the 8.6g glucosamine hydrochloride is dissolved in 30ml water and the 10ml acetone mixed solvent; the regulator solution pH value is 8～10; under the ice-water bath condition, drip acrylate chloride 3.5ml; slowly be warming up to room temperature behind the reaction 2h; continue reaction 24h, add 99% ethanol termination reaction, remove by filter the salt that reaction produces; filtrate concentrates the adularescent needle-like crystal and separates out recrystallization purification crystal.
(3) preparation of N-acryl glucosamine modified PE GDA gel
Preparation glucosamine modified PE GDA hydrogel comprises the steps: that (1) is dissolved in 0.5g polyoxyethylene glycol double methacrylate and 5.8mg N-acrylamido glucose the phosphate buffer solution of pH value 7.4 of the I2959 of 5ml 0.08%; The ultimate density of N-acrylamido glucose is 5.0mM in the mixed solution that obtains, and the ultimate density of polyoxyethylene glycol double methacrylate is that 10wt% (2) is a mould with 96 orifice plates, draw 40ul step (1) solution and place orifice plate, and at 365nm, 8mW/cm
2Under the UV-light according to 5min gelatinous material of the present invention.
Glucosamine modified PE GDA gelinite outer package GFP-BMSCs step: (1) is with disinfectant 1.0g polyoxyethylene glycol double methacrylate and 11.6mg N-acrylamido glucose are dissolved in the I2959PBS solution of 5ml 0.08%; (2) draw the above-mentioned solution of 2ml, mix with the bone marrow interstital stem cell suspension of equivalent green fluorescent protein mark; (3) be mould with 96 orifice plates, draw step 2 solution 40ul in orifice plate, at 365nm, 8mW/cm
2According to 5min, place 24 orifice plates to cultivate the gel cell conjugate under the UV-light.
Control group: the bone marrow interstital stem cell step of PEGDA gelinite outer package green fluorescent protein mark: (1) disinfectant 1.0g polyoxyethylene glycol double methacrylate is dissolved in the I2959PBS solution of 5ml 0.08%; (2) draw the above-mentioned solution of 2ml, mix with the bone marrow interstital stem cell suspension of equivalent green fluorescent protein mark; (3) be mould with 96 orifice plates, draw step 2 solution 40ul in orifice plate, at 365nm, 8mW/cm
2According to 5min, place 24 orifice plates to cultivate the gel cell conjugate under the UV-light.
Fig. 5 is the bone marrow interstital stem cell of the gel encapsulation green fluorescent protein mark of embodiment 3 preparations, cultivates 28 days glycosaminoglycan result.The result shows that glucosamine modified PE GDA can promote the bone marrow interstital stem cell of green fluorescent protein mark to be divided into cartilage, improves the secretory volume of extracellular matrix glycosaminoglycan.
Embodiment 4
(1) the polyoxyethylene glycol double methacrylate is synthetic
Take by weighing the polyoxyethylene glycol (number-average molecular weight 10000) of 50 grams; be dissolved in the 700ml toluene; reflux; after removing moisture content in the raw material with water trap; be cooled to room temperature, under high purity nitrogen protection, add 0.04 mole of anhydrous triethylamine; dropwise add 0.04 mol propylene acyl chlorides, stirred 24 hours down at 35 ℃.Remove by filter the triethylamine salt that reaction generates, add 300 milliliters of ether in the filtrate and place 4 ℃ of refrigerators, separate out white precipitate, filter, to precipitate and be dissolved in again in the 100ml benzene, add 200 milliliters of ether, separate out white precipitate in 4 ℃ of refrigerators, repeat to filter and dissolve twice, the gained white precipitate is in the dry 24h of 35 ℃ of vacuum drying ovens again.
(2) the glucosamine allyl ether is synthetic:
It is in 8～10 the aqueous solution, to be catalyzer with the sodium borohydride that the 20g glucosamine hydrochloride is dissolved in pH value, under 40 ℃, dropwise adds allyl bromide 98 30g, slowly is warming up to 60 ℃ of reaction 3h then, and solution washs to chloroform layer colourless through chloroform.The lyophilize of aqueous solution part, ethyl alcohol recrystallization.The feed ratio of glucosamine hydrochloride and allyl bromide 98 (ratio of amount of substance) is: 1: 3.
(3) preparation of glucosamine modified PE GDA gel
Preparation glucosamine modified PE GDA hydrogel comprises the steps: that (1) is dissolved in 1.0g polyoxyethylene glycol double methacrylate and 1.1mg glucosamine allyl ether the phosphate buffer solution of pH value 7.4 of the I2959 of 5ml 0.08%; The ultimate density of glucosamine allyl ether is 1.0mM in the mixed solution that obtains, and the ultimate density of polyoxyethylene glycol double methacrylate is that 20wt% (2) is a mould with 96 orifice plates, draw 40ul step (1) solution and place orifice plate, and at 365nm, 10mW/cm
2Under the UV-light according to 4min gelatinous material of the present invention.
Fig. 6 is the structural formula of embodiment 4 gels, and n is 230.
Claims (7)
1. glucosamine modified poly (ethylene glycol) diacrylate (PEGDA) hydrogel is characterized in that: have following structure:
Wherein R is
Or
N is 45～230.
2. the preparation method of the described a kind of glucosamine modified poly (ethylene glycol) diacrylate (PEGDA) hydrogel of claim 1 is characterized in that, specifically comprises the steps:
(1) glucosamine acryloyl derivative or glucosamine propenyl derivatives and polyoxyethylene glycol double methacrylate are dissolved in the aqueous solution or the phosphate buffer solution that weight fraction is 2-hydroxyl-4-(2-hydroxy ethoxy)-2-methyl phenyl ketone of 0.03%～0.08%, the ultimate density of glucosamine acryloyl or propenyl derivatives is 1.0mM～10.0mM in the mixed solution that obtains, and the ultimate density of polyoxyethylene glycol double methacrylate is 10%～30wt%;
(2) mixed solution is shone 4～10min under the 365nm wavelength, the irradiates light light intensity is 5～10mW/cm
2, promptly get glucosamine modified poly (ethylene glycol) diacrylate (PEGDA) hydrogel of the present invention.
3. preparation method according to claim 2 is characterized in that, described glucosamine acryloyl derivative comprises N-acryl glucosamine.
4. preparation method according to claim 3 is characterized in that, the preparation method of described N-acryl glucosamine comprises the steps:
(1) mixed solvent of glucosamine hydrochloride is water-soluble or water and acetone, regulating the pH value is 8～10, drips acrylate chloride under the ice-water bath condition, slowly be warming up to room temperature behind the reaction 2h, continue reaction 24h, add 99% volume ethanol termination reaction, remove by filter precipitation
(2) filtrate concentrating separated out white needle-like crystals, recrystallization purification crystal; The mol ratio of glucosamine hydrochloride and acrylate chloride is 1: 1.5～1: 1.
5. preparation method according to claim 2 is characterized in that, described glucosamine propenyl derivatives comprises the glucosamine allyl ether.
6. preparation method according to claim 4 is characterized in that, the preparation method of described glucosamine allyl ether is as follows:
The pH value of aqueous solution of regulating glucosamine hydrochloride is 8～10, adds sodium borohydride, under 40 ℃, dropwise adds allyl bromide 98, slowly is warming up to 60 ℃ of reaction 3h then, and solution washs to chloroform layer colourless through chloroform; With the lyophilize of aqueous solution part, ethyl alcohol recrystallization; The mol ratio of glucosamine hydrochloride and allyl bromide 98 is 1: 1.5～1: 3.
7. the application of the described a kind of glucosamine modified poly (ethylene glycol) diacrylate (PEGDA) hydrogel of claim 1 in cartilage tissue engineered.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101998784A CN101864046B (en) | 2010-06-11 | 2010-06-11 | Glucosamine modified poly (ethylene glycol) diacrylate (PEGDA) hydrogel, preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101998784A CN101864046B (en) | 2010-06-11 | 2010-06-11 | Glucosamine modified poly (ethylene glycol) diacrylate (PEGDA) hydrogel, preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101864046A true CN101864046A (en) | 2010-10-20 |
| CN101864046B CN101864046B (en) | 2012-09-26 |
Family
ID=42955994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101998784A Active CN101864046B (en) | 2010-06-11 | 2010-06-11 | Glucosamine modified poly (ethylene glycol) diacrylate (PEGDA) hydrogel, preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101864046B (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108744025A (en) * | 2018-05-30 | 2018-11-06 | 中山大学 | It is a kind of to be used to promote antioxygenic property hydrogel of wound healing and its preparation method and application |
| CN108841776A (en) * | 2018-06-13 | 2018-11-20 | 河海大学常州校区 | A kind of preparation method and application of the regulatable 3D gel of ingredient |
| CN108906007A (en) * | 2018-07-20 | 2018-11-30 | 河南中医药大学 | A kind of preparation method and applications of the hydrophilic magnetic composite microballoon of glycosyl |
| CN111875803A (en) * | 2020-07-03 | 2020-11-03 | 湖南航天三丰科工有限公司 | Organic silicon containing polyethylene glycol and preparation method thereof |
| CN111875752A (en) * | 2020-08-18 | 2020-11-03 | 福建梁野山农业开发有限公司 | Nano-selenium composite material and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1895773A (en) * | 2006-06-15 | 2007-01-17 | 南开大学 | Chromatographic fixed-phase for modified glycan substrate, its preparation and use |
| EP2149581A1 (en) * | 2007-04-20 | 2010-02-03 | Institut Molekulyarnoi Biologii Im. V.A. Engelgardta Rossiiskoi Akademii Nauk | Monomer and composition for producing low-percentage hydrogel and/or hydrogel having a low cross linkage content, a hydrogel and a biochip based thereon |
-
2010
- 2010-06-11 CN CN2010101998784A patent/CN101864046B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1895773A (en) * | 2006-06-15 | 2007-01-17 | 南开大学 | Chromatographic fixed-phase for modified glycan substrate, its preparation and use |
| EP2149581A1 (en) * | 2007-04-20 | 2010-02-03 | Institut Molekulyarnoi Biologii Im. V.A. Engelgardta Rossiiskoi Akademii Nauk | Monomer and composition for producing low-percentage hydrogel and/or hydrogel having a low cross linkage content, a hydrogel and a biochip based thereon |
Non-Patent Citations (1)
| Title |
|---|
| 《Chinese Chemical Letters》 20081231 Hai Li Zhao et al Hemoglobin-imprinted polymer gel prepared using modified glucosamine as functional monomer 233-236 1-6 第19卷, 2 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108744025A (en) * | 2018-05-30 | 2018-11-06 | 中山大学 | It is a kind of to be used to promote antioxygenic property hydrogel of wound healing and its preparation method and application |
| CN108744025B (en) * | 2018-05-30 | 2021-09-03 | 中山大学 | Antioxidant hydrogel for promoting wound healing and preparation method and application thereof |
| CN108841776A (en) * | 2018-06-13 | 2018-11-20 | 河海大学常州校区 | A kind of preparation method and application of the regulatable 3D gel of ingredient |
| CN108906007A (en) * | 2018-07-20 | 2018-11-30 | 河南中医药大学 | A kind of preparation method and applications of the hydrophilic magnetic composite microballoon of glycosyl |
| CN111875803A (en) * | 2020-07-03 | 2020-11-03 | 湖南航天三丰科工有限公司 | Organic silicon containing polyethylene glycol and preparation method thereof |
| CN111875752A (en) * | 2020-08-18 | 2020-11-03 | 福建梁野山农业开发有限公司 | Nano-selenium composite material and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101864046B (en) | 2012-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| He et al. | Tannic acid-reinforced methacrylated chitosan/methacrylated silk fibroin hydrogels with multifunctionality for accelerating wound healing | |
| Amirian et al. | In-situ crosslinked hydrogel based on amidated pectin/oxidized chitosan as potential wound dressing for skin repairing | |
| US20230130084A1 (en) | Modified alginates for cell encapsulation and cell therapy | |
| Lin et al. | Influence of physical properties of biomaterials on cellular behavior | |
| Yuan et al. | An M2 macrophage-polarized anti-inflammatory hydrogel combined with mild heat stimulation for regulating chronic inflammation and impaired angiogenesis of diabetic wounds | |
| Guo et al. | Hydrogels of collagen/chondroitin sulfate/hyaluronan interpenetrating polymer network for cartilage tissue engineering | |
| CN102942660B (en) | Natural biological crosslinking nanocomposite three-dimensional gel bracket and preparation method | |
| CN101864046B (en) | Glucosamine modified poly (ethylene glycol) diacrylate (PEGDA) hydrogel, preparation method and application thereof | |
| CN102585267B (en) | Intelligent gel three-dimensional scaffold material for cell culture | |
| Safarzadeh Kozani et al. | Polysaccharide-based hydrogels: Properties, advantages, challenges, and optimization methods for applications in regenerative medicine | |
| WO2012057751A1 (en) | Crosslinked cellulosic polymers | |
| CN109966558A (en) | A kind of injectable intelligent response hydrogel and its preparation method and application | |
| CN102250390A (en) | Alginate hydrogel microcarrier and preparation method thereof | |
| CN1775302A (en) | Chitose-gelatine sponge wound dressing preparing method | |
| Li et al. | On‐site alginate gelation for enhanced cell proliferation and uniform distribution in porous scaffolds | |
| CN112812329B (en) | Hydrogel of sulfhydryl modified high molecular compound, preparation method and application thereof | |
| Kil’deeva et al. | Biodegradablescaffolds based on chitosan: Preparation, properties, and use for the cultivation of animal cells | |
| Sang et al. | Photo-crosslinked hydrogels for tissue engineering of corneal epithelium | |
| Liu et al. | Citric acid cross‐linked chitosan for inhibiting oxidative stress after nerve injury | |
| Wei et al. | Enzymatic one-pot preparation of carboxylmethyl chitosan-based hydrogel with inherent antioxidant and antibacterial properties for accelerating wound healing | |
| Zhang et al. | Chitosan based macromolecular hydrogel loaded total glycosides of paeony enhances diabetic wound healing by regulating oxidative stress microenvironment | |
| CN114479204B (en) | Composite crosslinked medical polymer material and preparation method and application thereof | |
| CN113754903B (en) | Preparation method of double-crosslinked hyaluronic acid/chitosan composite hydrogel for skin repair | |
| CN113956506B (en) | Double-network hydrogel and preparation method and application thereof | |
| CN113171497A (en) | Budesonide-loaded silk fibroin/chitosan composite porous scaffold |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |